S&P 500 Futures
(0.04%) 5 519.25 points
Dow Jones Futures
(0.15%) 39 904 points
Nasdaq Futures
(0.08%) 19 767 points
Oil
(0.02%) $81.65
Gas
(0.50%) $2.83
Gold
(-0.25%) $2 338.50
Silver
(0.15%) $29.57
Platinum
(0.61%) $1 007.90
USD/EUR
(0.14%) $0.933
USD/NOK
(-0.08%) $10.52
USD/GBP
(0.03%) $0.788
USD/RUB
(-0.85%) $87.25

Aktualne aktualizacje dla Lexeo Therapeutics, Inc. [LXEO]

Giełda: NASDAQ Sektor: Healthcare Branża: Biotechnology
Ostatnio aktualizowano24 birž. 2024 @ 23:00

4.94% $ 17.00

Live Chart Being Loaded With Signals

Commentary (24 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by -0.10% compare to its pairs and should correct downwards.

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich\'s ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations...

Stats
Dzisiejszy wolumen 228 147
Średni wolumen 141 719
Kapitalizacja rynkowa 560.07M
EPS $-0.770 ( Q1 | 2024-03-31 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0490 (0.29%)
AADI 3.55%
ABCL -3.79%
ABCM 0.04%
ABEO -5.02%
ABIO -0.29%
ABOS -3.03%
ABSI 0.66%
ABUS 0.66%
ABVX 2.61%
ACAD 3.79%
ACER -17.95%
ACET 9.49%
ACGN 1.29%
ACHL 0.22%
ACHV -4.83%
ACIU 2.47%
ACLX -0.09%
ACRV -5.30%
ACST -0.31%
ACXP -2.15%
ADAG 0.69%
ADAP -1.06%
ADGI 0.87%
ADIL 2.68%
ADMA 0.09%
ADPT 1.54%
ADTX -2.08%
ADVM 1.63%
ADXN -5.75%
AEON -7.34%
AEZS -1.10%
AFMD 1.02%
AGEN 4.60%
AGIO 0.02%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -0.69%
AKRO 2.80%
AKTX -1.08%
AKUS 0.00%
ALBO 0.00%
ALDX -5.46%
ALEC 0.44%
ALGS -4.88%
ALKS -1.28%
ALLK 8.11%
ALLO 2.35%
ALLR -28.40%
ALNA 3.16%
ALNY 34.52%
ALPN 0.02%
ALPX 0.00%
ALRN -1.60%
ALT 11.39%
ALVR 4.92%
ALXN 0.00%
ALXO -0.15%
ALZN -7.26%
AMRN 2.72%
AMTI -3.13%
ANAB 0.21%
ANEB -1.49%
ANGN 0.00%
ANIX -0.79%
ANL 0.29%
ANNX -4.22%
ANPC -3.15%
APGE 2.63%
APGN 8.48%
APGNW 30.65%
APLM 9.95%
APLS 0.92%
APLT 1.76%
APM 1.73%
APOP 0.38%
APRE 3.24%
APTO -2.37%
APTX 3.17%
APVO 1.15%
ARAV -13.39%
ARCT -0.44%
ARDS 2.49%
ARDX 1.46%
ARGX 11.69%
ARNA 0.00%
ARPO -0.90%
ARQT 4.59%
ARTL -2.71%
ARTLW 0.00%
ARVN -0.99%
ARWR 6.82%
ASLN -2.99%
ASMB 0.38%
ASND 1.20%
ATAI 4.48%
ATHA 1.28%
ATHE 2.27%
ATHX -33.50%
ATNF 2.05%
ATOS -5.31%
ATRA 0.67%
ATXI 9.52%
ATXS -2.65%
AUPH 2.35%
AURA -1.25%
AUTL -2.87%
AVBP -0.78%
AVEO 0.00%
AVIR 1.45%
AVRO -1.41%
AVTE -3.85%
AVTX 2.99%
AVXL 3.19%
AXLA 0.00%
AXSM 2.76%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO -15.94%
BCAB 3.31%
BCDA -5.67%
BCDAW -39.75%
BCEL 0.00%
BCLI 2.70%
BCRX -2.34%
BCTX -7.44%
BCTXW -18.26%
BCYC 0.10%
BDRX -15.63%
BDTX 0.83%
BEAM 8.24%
BFRA -2.91%
BGNE 1.95%
BIOR 1.50%
BIVI 0.96%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX 3.39%
BLTE 0.27%
BLU 0.03%
BLUE 13.45%
BMEA 5.51%
BMRN 1.62%
BNOX 2.99%
BNTC 4.80%
BNTX 2.33%
BOLD 13.42%
BOLT -1.45%
BPMC 1.79%
BPTH 0.88%
BPTS -13.47%
BRNS 0.00%
BRTX 1.72%
BTAI 4.39%
BTTX 0.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI -1.78%
CABA -1.53%
CADL 1.82%
CALA 0.00%
CALC -1.87%
CALT 1.83%
CAPR 1.91%
CARA 22.71%
CARM 9.80%
CASI 7.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -4.40%
CCCC 11.08%
CCXI 0.00%
CDAK 0.00%
CDIO -0.17%
CDIOW 36.86%
CDMO -4.38%
CDMOP 0.04%
CDT -7.05%
CDTTW -23.91%
CDTX -2.84%
CDXC -6.59%
CDXS 2.04%
CELC 4.58%
CELU 0.66%
CELUW 11.18%
CERC -1.68%
CERE -0.55%
CERO 2.09%
CEROW -22.90%
CFRX -27.95%
CGEM -0.34%
CGEN -5.08%
CGON 1.50%
CGTX -2.63%
CHMA -6.00%
CHRS -2.40%
CINC 0.00%
CING 4.73%
CINGW 73.79%
CKPT 15.56%
CLBS -16.75%
CLDX 2.55%
CLGN 6.22%
CLLS 1.06%
CLNN -3.46%
CLNNW -33.25%
CLRB 0.00%
CLSD 0.00%
CLSN -0.68%
CLVS 0.00%
CMMB 8.57%
CMND -7.59%
CMPI 0.00%
CMPX 0.91%
CMRA 0.00%
CMRAW 33.33%
CMRX 1.85%
CNCE 0.00%
CNSP 12.63%
CNST 0.00%
CNTA -2.31%
CNTB -6.25%
CNTX 0.93%
COCP -1.88%
COEPW 0.00%
COGT 1.14%
CORT 1.83%
COYA -2.48%
CPRX -1.28%
CRBP 2.42%
CRBU 8.72%
CRDF -3.67%
CRGX 4.50%
CRIS 3.02%
CRNX 0.18%
CRSP 3.02%
CRTX 2.63%
CRVO 0.40%
CRVS 2.81%
CSBR -1.20%
CTCX -7.84%
CTIC 0.06%
CTMX 3.10%
CTNM 3.23%
CTXR 4.68%
CUE 8.89%
CVAC 6.44%
CVKD 6.24%
CWBR 0.00%
CYAD -12.96%
CYCC -5.01%
CYCCP 4.03%
CYCN 6.69%
CYT -2.27%
CYTK 0.71%
CYTO 2.61%
DARE 1.96%
DAWN -1.10%
DBTX -0.81%
DBVT -1.80%
DFFN 10.28%
DICE 0.06%
DMAC 2.78%
DNLI 1.24%
DNTH -0.04%
DOMH -2.63%
DRMA 12.50%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.62%
DRTSW 0.00%
DRUG -3.77%
DSGN -0.59%
DTIL 0.85%
DYAI -9.66%
EARS -1.77%
EDIT -0.59%
EDSA -0.11%
EFTR -75.81%
EFTRW -96.33%
EIGR -9.21%
ELAB 0.86%
ELDN -4.40%
ELEV -4.30%
ELOX 0.00%
ELTX 6.89%
ELVN 1.87%
ELYM -8.69%
ENGN -9.67%
ENGNW -7.87%
ENLV 3.68%
ENOB 1.79%
ENSC 4.98%
ENTA 2.43%
ENTO -2.13%
ENTX 1.98%
ENVB 9.19%
EPIX -1.02%
EPRX 0.57%
EPZM 0.00%
EQ 2.52%
EQRX -2.09%
EQRXW 0.00%
ERAS 2.37%
ERNA -4.64%
ERYP 1.30%
ESLA -0.50%
ESLAW 0.00%
ETNB -0.82%
ETON -0.60%
ETTX 0.00%
EVAX -5.28%
EVGN -2.18%
EVLO 0.00%
EWTX -1.99%
EXAI -2.78%
EXEL 0.54%
EYEG 0.11%
EYEN 2.28%
EYPT 0.59%
FATE 2.13%
FBIO -3.95%
FBIOP 0.59%
FBLG 5.49%
FBRX 0.27%
FDMT 1.35%
FENC -1.09%
FGEN 6.19%
FHTX 0.38%
FIXX 0.77%
FMTX 0.00%
FNCH -6.77%
FOLD -0.89%
FREQ 4.76%
FRLN 0.15%
FRTX -4.51%
FSTX 0.00%
FTRE -0.65%
FULC -5.09%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -8.97%
GANX 0.00%
GBIO 1.45%
GBT 0.01%
GDTC 5.61%
GERN -1.29%
GHRS 0.42%
GLMD -1.83%
GLPG 1.67%
GLSI -4.73%
GLTO 5.51%
GLUE 4.96%
GLYC 3.61%
GMAB -0.81%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT 1.29%
GNLX 10.68%
GNPX 0.00%
GNTA 7.74%
GOSS 27.09%
GOVX 30.04%
GOVXW 49.24%
GPCR -4.15%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 4.76%
GRTX 40.48%
GTHX -10.48%
GUTS 5.77%
GXGXW 41.67%
GYRE -3.28%
HALO 0.99%
HARP 0.09%
HCWB 10.69%
HEPA 5.42%
HGEN -84.62%
HILS 5.66%
HLVX 2.75%
HOOK -1.07%
HOTH 0.67%
HOWL -9.38%
HRMY -0.10%
HRTX -1.55%
HSTO 0.00%
HUMA -1.35%
HUMAW 5.19%
IBRX 1.10%
ICCC -0.22%
ICPT 0.21%
ICU 10.12%
ICUCW 14.68%
ICVX -0.91%
IDRA -23.04%
IDYA 0.03%
IFRX 8.44%
IGMS 0.00%
IKNA -2.33%
IKT -5.00%
IMAB 2.38%
IMCR -0.28%
IMGN 0.02%
IMGO 0.00%
IMMP -2.92%
IMMX 11.76%
IMNM -4.02%
IMNN -4.46%
IMPL -27.27%
IMRA 15.96%
IMRN 12.11%
IMRX 4.20%
IMTX -1.37%
IMTXW -14.50%
IMUX -0.90%
IMV 0.00%
IMVT 0.18%
INAB -0.84%
INBX 2.18%
INCY 0.84%
INDP -1.33%
INFI -52.38%
INKT -1.62%
INM 9.72%
INMB 1.62%
INO -1.61%
INSM 0.65%
INTS 4.74%
INVA 0.63%
INZY 0.67%
IOBT 0.00%
IONS 6.81%
IOVA 1.87%
IPA -1.92%
IPHA -5.16%
IPSC -6.29%
IRON 1.81%
ISEE 0.38%
ITOS 0.61%
ITRM -5.65%
IVA -0.71%
IVVD 2.42%
JAGX -3.32%
JANX 5.52%
JAZZ 1.72%
JNCE 0.00%
JSPR 1.72%
JSPRW 4.71%
JUNS 0.00%
JUNSW 0.00%
KA 13.13%
KALV -0.17%
KDNY 0.22%
KMPH -0.34%
KNSA 1.40%
KNTE -0.38%
KOD 3.41%
KPRX 9.68%
KPTI 12.76%
KRBP -0.40%
KRON -6.48%
KROS 0.09%
KRRO -0.76%
KRTX 0.03%
KRYS 1.97%
KTRA 6.15%
KTTA 4.85%
KTTAW -5.17%
KURA 0.67%
KYMR -1.69%
KYTX 2.07%
KZIA -15.51%
KZR 1.12%
LABP 0.57%
LBPH 0.05%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.13%
LENZ -1.52%
LEXX -1.49%
LEXXW -0.19%
LGND 0.72%
LGNDV 0.00%
LGVN -12.73%
LIAN -8.28%
LIFE 2.70%
LIPO 10.88%
LIXT -1.57%
LIXTW 0.00%
LJPC -0.32%
LMNL 0.12%
LOGC 1.27%
LPCN 3.56%
LPTX -2.08%
LQDA 3.28%
LRMR -10.33%
LSTA -3.26%
LTRN -5.78%
LUMO 1.79%
LVTX 0.27%
LXEO 4.94%
LXRX -2.16%
LYEL 3.41%
LYRA -2.78%
MACK 0.10%
MBIO 2.70%
MBRX -3.48%
MCRB -2.19%
MDGL 2.00%
MDNA -13.16%
MDWD 7.88%
MDXG -1.02%
MEIP -2.80%
MESO -3.28%
MGNX 2.97%
MGTA -7.74%
MGTX -3.18%
MGX 0.56%
MIRM 8.74%
MIRO 0.59%
MIST 0.72%
MITO 0.00%
MLEC -5.36%
MLECW 90.24%
MLND -5.36%
MLTX 0.73%
MLYS 4.90%
MNKD 6.26%
MNMD 0.27%
MNOV 0.00%
MNPR 15.76%
MOLN -25.10%
MOR -0.11%
MORF 10.26%
MREO -5.53%
MRKR 9.03%
MRNA 2.70%
MRNS 3.01%
MRSN 3.76%
MRTX -0.17%
MRUS 3.77%
MRVI -2.35%
MTCR -1.29%
MTEM -4.59%
MTP -18.50%
MURA -0.62%
MYMD -4.12%
NAMS 8.93%
NAMSW 26.87%
NAUT -8.57%
NBRV 0.71%
NBSE -1.56%
NBTX 4.81%
NCNA -0.34%
NERV -5.52%
NEXI -2.44%
NGM -1.28%
NGNE 2.39%
NKGN 0.00%
NKGNW 8.00%
NKTR 0.86%
NKTX 1.82%
NLSP -5.16%
NLSPW 28.30%
NMRA 0.00%
NMTR -42.97%
NOVN -24.84%
NRBO 0.49%
NRIX -1.27%
NRSN -3.99%
NRSNW 0.00%
NRXP 0.75%
NRXPW 0.00%
NRXS -0.78%
NTBL 0.36%
NTEC -12.45%
NTHI 0.00%
NTLA 3.22%
NTRBW 0.00%
NUVL 1.72%
NVAX 0.14%
NVCT 2.13%
NVIV -34.28%
NXTC 3.70%
NYMX -0.05%
OABI 1.75%
OABIW -3.65%
OBIO 9.02%
OBSV 0.00%
OCEA 7.75%
OCGN -5.26%
OCS 1.37%
OCUL 4.48%
OCUP 1.27%
ODT -4.27%
OKYO -1.63%
OLMA 2.15%
OMER 2.90%
OMGA -0.41%
ONCO -6.85%
ONCR -3.08%
ONCS 31.87%
ONCT -1.85%
ONCY 0.00%
ONTX -0.47%
ONVO -2.28%
OPNT 0.00%
OPT -4.93%
ORGS -3.25%
ORIC -1.11%
ORMP -3.04%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.62%
OVID 1.28%
OYST 0.00%
PALI -3.95%
PASG 0.00%
PBLA -4.76%
PBM -4.74%
PBYI -2.34%
PCSA 0.51%
PCVX 1.12%
PDSB 8.33%
PEPG 4.57%
PGEN 4.55%
PHAR 13.76%
PHAS 0.00%
PHAT -2.26%
PHIO 3.65%
PHIOW 36.47%
PHVS -4.62%
PHXM -5.20%
PIRS -5.56%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 3.28%
PLUR -0.44%
PMN -0.63%
PMVP 4.64%
PNT 0.16%
PPBT 5.78%
PRAX -2.61%
PRDS 0.93%
PRLD 2.88%
PROG -3.47%
PROK -7.60%
PRQR -3.51%
PRTA 0.56%
PRTC -6.90%
PRTG -0.04%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -11.11%
PSTX -1.08%
PTCT -2.05%
PTE -0.82%
PTGX -0.78%
PTIXW -5.10%
PULM -2.53%
PXMD 0.00%
PYPD -1.97%
PYXS -5.34%
QLGN -8.10%
QNCX 0.71%
QNRX 1.44%
QSI 0.84%
QSIAW 1.20%
QTTB -0.71%
QURE -1.09%
RAIN -1.63%
RANI -0.96%
RAPT 3.18%
RARE -0.45%
RCKT 7.03%
REGN 1.02%
RENB 1.27%
REPL 3.06%
RETA 0.02%
REUN -0.89%
REVB 13.74%
REVBU 3.46%
REVBW 50.29%
RGLS -18.33%
RGNX 6.41%
RIGL 0.65%
RLAY -0.58%
RLMD -0.99%
RLYB 5.48%
RNA 1.69%
RNAC 1.05%
RNAZ 5.27%
RNXT 4.09%
ROIV 2.06%
ROIVW 4.56%
RPHM 0.00%
RPRX 0.74%
RPTX 0.28%
RUBY 2.70%
RVLP -32.05%
RVMD 0.76%
RVMDW 17.51%
RVNC -3.38%
RVPH 2.40%
RVPHW 1.92%
RXDX 0.09%
RXRX 5.54%
RYTM 1.58%
RYZB 0.02%
RZLT 7.85%
SABS 4.23%
SABSW -35.81%
SAGE 3.86%
SANA 0.54%
SAVA -1.10%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -6.67%
SCPH 1.24%
SCPS 0.00%
SEEL -2.49%
SEER 1.76%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 5.62%
SGMT 6.87%
SGTX -2.56%
SIOX 22.63%
SLDB 2.48%
SLGL 0.59%
SLN 3.61%
SLNO -2.60%
SLRX -3.97%
SLS -0.82%
SMMT 0.88%
SNDX -1.25%
SNGX -2.31%
SNPX 5.67%
SONN -6.53%
SPPI -0.49%
SPRB 5.39%
SPRC -2.42%
SPRO -2.92%
SRNE 15.79%
SRPT 1.95%
SRRA 0.00%
SRRK -0.47%
SRZN 5.26%
STAB 0.00%
STOK 0.70%
STRO -4.95%
STSA 0.00%
STTK -9.50%
SURF -0.93%
SVRA -5.67%
SWTX -0.17%
SYBX 2.01%
SYRS 4.12%
TALS -0.73%
TARA -1.33%
TARS 1.36%
TBPH 0.23%
TCBP -8.11%
TCDA 0.00%
TCON -1.60%
TCRR 0.00%
TCRT -3.84%
TCRX 2.92%
TECH 1.13%
TENX 9.03%
TERN 4.01%
TFFP 9.20%
TGTX 4.31%
THRX 0.12%
TIL -3.68%
TLC 0.00%
TLSA 14.49%
TNGX 0.50%
TNXP -8.46%
TNYA -0.96%
TPST 2.96%
TRDA -4.11%
TRVI -2.22%
TRVN -13.99%
TSHA -10.14%
TSVT 3.76%
TTNP -14.84%
TVTX 6.57%
TYRA 0.35%
UBX 0.36%
UNCY 7.44%
URGN 5.81%
UTHR 0.92%
VACC 11.36%
VALN 12.99%
VAXX -10.53%
VBIV 3.44%
VBLT -8.77%
VCEL 2.64%
VCNX -0.49%
VCYT 1.77%
VERA -2.79%
VERU 9.04%
VERV -0.19%
VIGL 0.52%
VINC -1.38%
VIR 0.22%
VIRI -1.85%
VIRX -5.63%
VKTX -1.18%
VLON -13.04%
VNDA -2.29%
VOR 4.20%
VRCA -4.56%
VRDN 5.09%
VRNA 4.60%
VRPX -4.95%
VRTX 1.33%
VSTM -1.90%
VTGN -3.58%
VTVT 0.00%
VTYX -0.80%
VXRT 5.82%
VYGR -0.43%
VYNE -4.95%
VYNT 7.78%
WINT 7.90%
WVE -0.76%
XBIO -5.83%
XBIT -12.02%
XCUR -3.35%
XENE -0.21%
XERS 0.00%
XFOR 0.00%
XLO 2.47%
XLRN 0.00%
XNCR 1.46%
XOMA 5.64%
XOMAO -0.20%
XOMAP -0.76%
XRTX -2.38%
YMAB 0.83%
ZGNX 0.00%
ZIOP -0.88%
ZLAB 0.97%
ZNTL -3.16%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-11-07 Omega Fund Vi, L.p. Buy 454 545 Common Stock
2023-11-07 Omega Fund Vi, L.p. Buy 287 213 Common Stock
2023-11-07 Omega Fund Vi, L.p. Buy 1 415 865 Common Stock
2023-11-07 Omega Fund Vi, L.p. Sell 2 615 533 Series B convertible preferred stock
2023-11-07 Omega Fund Vi, L.p. Sell 14 999 999 Series A convertible preferred stock
INSIDER POWER
-79.48
Last 16 transactions
Buy: 4 724 723 | Sell: 41 348 236
Korelacja (AI algo v.1.1b): Overvalued: -0.10% $17.02 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: 0.08 (neutral)
Krótki: 0.70 (moderate)
Signal:(57.895) Neutral

Lexeo Therapeutics, Inc. Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lexeo Therapeutics, Inc. Korelacja - Waluta/Towar

The country flag -0.34
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.50
( weak negative )
The country flag -0.23
( neutral )
The country flag 0.09
( neutral )

Lexeo Therapeutics, Inc. Finanse

Annual 2022
Przychody: $654 000
Zysk brutto: $654 000 (100.00 %)
EPS: $-2.40
FY 2022
Przychody: $654 000
Zysk brutto: $654 000 (100.00 %)
EPS: $-2.40

Financial Reports:

No articles found.

Lexeo Therapeutics, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich\'s ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej

Total Execution Time: 1.1363999843597 seconds
Number of API calls: 3
Number of DB calls: 9